Observational studyEye (London, England)2025

Aflibercept 2 mg biosimilar (Tyalia)-real-world experience from IRAN (ATRIA study).

Sahar Avadzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.